Evidence map›Paper›PMID 38133302›Full record

ReviewPathogens (Basel, Switzerland)2023

Why the SAFE-

Carla Enrica Gallenga, Martina Maritati, Marco Del Boccio, Rossella D'Aloisio, Pio Conti, Marco Mura, Carlo Contini, Pier Enrico Gallenga

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Addressing Challenges inMedicina (Kaunas, Lithuania) · 2024
    Review
  2. Article
  3. AboutPathogens (Basel, Switzerland) · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Carla Enrica GallengaDepartment of Medical Science, University of Ferrara, Eye Clinic University-Hospital, 44124 Ferrara, Italy.ORCID 0000-0002-7426-8603
Martina MaritatiDepartment of Medical Science Infectious Diseases and Dermatology Section, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-9938-8492
Marco Del BoccioCentro Medico Santa Lucia, 66054 Vasto, Italy.
Rossella D'AloisioDepartment of Medical, Oral, and Biotechnological Sciences, G. d'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.
Pio ContiMolecular Immunopharmacology and Drug Discovery Laboratory, Tufts University Medical School, Boston, MA 02111, USA.ORCID 0000-0002-9475-4924
Marco MuraDepartment of Traslational Medicine and for Romagna, Section Ophthalmology, University of Ferrara, 44124 Ferrara, Italy.
Carlo ContiniDepartment of Medical Science Infectious Diseases and Dermatology Section, University of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-8809-6470
Pier Enrico GallengaStenella cno Ophthalmology Laboratory, 65100 Pescara, Italy.
University of Ferrara · ITFondazione Santa Lucia · ITTufts University · USUniversity of Chieti-Pescara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biological history of

Indexed as

chlamydiaconjunctivitisMusca sorbensneglected transmitted diseasesRT-PCRsexually transmitted diseasestrachomavaccinesWHO SAFE strategy

Identifiers

PMID38133302
PMCPMC10748347
OpenAlexW4389304479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.